Craft

CVRx

Stock Price

$10.7

2024-10-29

Market Capitalization

$234 M

2024-10-29

Revenue

$56.7 M

FY, 2025

CVRx Summary

Company Summary

Overview
CVRx is a medical device company developing implantable technology for the treatment of high blood pressure/hypertension and heart failure patients. Its product BAROSTIM NEO, is a neuro-modulation therapy that triggers the body's natural reflex to regulate blood pressure and the underlying causes of the progression of heart failure.
Type
Public
Status
Active
Founded
2001
HQ
Minneapolis, MN, US | view all locations
Website
http://www.cvrx.com/
Cybersecurity rating
Sectors

Key People

  • Jared Oasheim

    Jared Oasheim, Chief Financial Officer

  • Joseph Slattery

    Joseph Slattery, Director

    LocationsView all

    1 location detected

    • Minneapolis, MN HQ

      United States

      9201 W Broadway Ave #650

    CVRx Financials

    Summary Financials

    Revenue (Q1, 2026)
    $14.8M
    Gross profit (Q1, 2026)
    $12.9M
    Net income (Q1, 2026)
    ($13.1M)
    Cash (Q1, 2026)
    $72.3M
    EBIT (Q1, 2026)
    ($12.2M)
    Enterprise value
    $220.7M

    Footer menu